St. Jude Medical, Inc. (STJ) Tops Q4 EPS by 2c; Guides Q1, FY12 EPS Below Views
Tweet
Share
E-mailGet Alerts STJ Hot Sheet
Price: $80.82 --0%
Financial Fact:
Research and development expense: 183M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Research and development expense: 183M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
St. Jude Medical, Inc. (NYSE: STJ) reported Q4 EPS of $0.86, $0.02 better than the analyst estimate of $0.84. Revenue for the quarter came in at $1.41 billion versus the consensus estimate of $1.4 billion.
St. Jude Medical, Inc. sees FY2012 EPS of $3.43-$3.48, versus the consensus of $3.51.
St. Jude Medical, Inc. sees Q1 2012 EPS of $0.82-$0.84, versus the consensus of $0.85.
For earnings history and earnings-related data on St. Jude Medical, Inc. (STJ) click here.
St. Jude Medical, Inc. sees FY2012 EPS of $3.43-$3.48, versus the consensus of $3.51.
St. Jude Medical, Inc. sees Q1 2012 EPS of $0.82-$0.84, versus the consensus of $0.85.
For earnings history and earnings-related data on St. Jude Medical, Inc. (STJ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Vivos Therapeutics posts 35% revenue gain but widens net loss
- Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
